CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The purpose of this study is to evaluate the safety and effectiveness of the TPV in patients with pulmonary valve dysfunction.
Seoul, Haehak-ro Jongno-gu, Korea, Republic of and 4 other locations
This study will evaluate the clinical efficacy and safety of udenafil, an orally administered, potent and selective inhibitor of PDE5, versus placebo...
Phase 3
Seoul, Korea, Republic of and 26 other locations
The purpose of the study is to evaluate the safety and effectiveness of the PULSTA Transcatheter Pulmonary Valve (TPV) System for the treatment of co...
Seoul, Haehak-ro Jongno-gu, Korea, Republic of and 10 other locations
The researchers are doing this study to look whether the type 2 diabetes medicine, semaglutide, has a positive effect on heart disease...
Phase 3
Seoul, Korea, Republic of and 468 other locations
the safety and efficacy of drug-coated balloon (DCB) treatment compared to drug-eluting stenting (DES) in patients with large coronary artery disease...
Seoul, Korea, Republic of and 19 other locations
The aim of this study is to assess the level of glycemic control and the incidence of surgery-related complications in cardiac patients post-surgery...
Seoul, Korea, Republic of
software to assist clinicians in the diagnosis of coronary artery disease by predicting coronary artery stenosis (≥50%) from a multimodal AI...
Seoul, Korea, Republic of and 4 other locations
This study will assess the effect of lowering low-density lipoprotein cholesterol (LDL-C) with evolocumab on major cardiovascular events in adults wi...
Phase 3
Seoul, Korea, Republic of and 851 other locations
The primary objective of this study is to assess the efficacy of a single dose of ravulizumab IV compared with placebo in reducing the risk of the cl...
Phase 3
Seoul, Korea, Republic of and 178 other locations
would improve clinical and echocardiographic outcomes in heart failure (HF) patients with functional tricuspid regurgitation (TR) and preser...
Phase 3
Seoul, Korea, Republic of and 4 other locations
Clinical trials
Research sites
Resources
Legal